Entero Therapeutics, Inc. (NASDAQ: ENTO) announced it will implement a 1-for-3 reverse stock split of its common stock, effective August ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE